In today’s pharmaceutical market access landscape, payers are not the sole decision-makers in utilization management development.
Kevin Tse
Advertisement
Kevin Tse, PharmD, VP, Value & Access, Formulary Insights
Articles by Kevin Tse
Advertisement
Latest Updated Articles
Biopharma Needs a Health System Strategy to Secure Optimal Market AccessPublished: November 1st 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
